Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Inhal Toxicol. 2007;19 Suppl 1:75-9.

Does inhalation of ultrafine particles cause pulmonary vascular effects in humans?

Author information

  • Department of Medicine, University of Rochester School of Medicine, Rochester, New York, USA. mark_frampton@urmc.rochester.edu

Abstract

Inhalation of ambient particulate matter increases the risk of cardiovascular disease. Clinical studies play an important role in elucidating mechanisms for pollutant effects, and in establishing ambient air quality standards. Ultrafine particles (UFP; diameter <100 nm) may be important in the cardiovascular effects of ambient PM, yet there are few clinical studies of UFP health effects. Our laboratory has developed an exposure facility for clinical studies of laboratory-generated UFP. We confirmed previous predictions that UFP <50 nm in diameter deposit in the respiratory tract with a high efficiency, and have shown that exercise or the presence of asthma further increases UFP deposition. UFP exposure with exercise reduced expression of selected adhesion molecules on blood leukocytes, and also decreased the pulmonary diffusing capacity for carbon monoxide. These findings are best explained by UFP effects on pulmonary vascular function. These findings provide a possible mechanism by which inhalation of UFP may contribute to cardiopulmonary health effects in susceptible people.

PMID:
17886054
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk